mofezolac has been researched along with Ischemic Stroke in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rostevanov, IS | 1 |
| Boyko, M | 1 |
| Ferorelli, S | 1 |
| Scilimati, A | 1 |
| Perrone, MG | 1 |
| Kaplanski, J | 1 |
| Zlotnik, A | 1 |
| Azab, AN | 1 |
1 other study available for mofezolac and Ischemic Stroke
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-1 does not reduce mortality in post-ischemic stroke rats.
Topics: Animals; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Ischemic Stroke; Isoxazol | 2020 |